metastatic breast cancer

Showing NaN - NaN of 36

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer, Metastatic Breast Cancer, Radiation Therapy Complication Trial in Seoul

Recruiting
  • Breast Cancer
  • +2 more
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 8, 2023

    Metastatic Breast Cancer Trial in Seoul (Fulvestrant plus AI plus ribociclib, AI plus ribociclib)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Fulvestrant plus AI plus ribociclib
    • AI plus ribociclib
    • Seoul, Korea, Republic of
      Korea university Guro hospital
    Apr 16, 2023

    Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)

    Recruiting
    • Metastatic Breast Cancer
    • Trastuzumab deruxtecan
    • +4 more
    • West Hollywood, California
    • +101 more
    Jan 16, 2023

    Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)

    Recruiting
    • Metastatic Breast Cancer
    • Trastuzumab deruxtecan
    • +6 more
    • Iowa City, Iowa
    • +60 more
    Jan 3, 2023

    Patterns and Associated Outcomes in HER2-positive Unresectable

    Completed
    • Metastatic Breast Cancer
    • None (Observational study)
    • Macquarie, New South Wales, Australia
    • +43 more
    Nov 23, 2022

    Metastatic Breast Cancer Trial in Worldwide (Trastuzumab Emtansine, Atezolizumab, Placebo)

    Recruiting
    • Metastatic Breast Cancer
    • Trastuzumab Emtansine
    • +2 more
    • Fountain Valley, California
    • +139 more
    Aug 17, 2022

    Metastatic Breast Cancer Trial in Worldwide (Abemaciclib)

    Available
    • Metastatic Breast Cancer
    • Liverpool, New South Wales, Australia
    • +229 more
    Aug 17, 2022

    Real-world Prescription Pattern of Palbociclib Combination

    Active, not recruiting
    • Metastatic Breast Cancer
    • Patients who received Palbociclib as first line therapy in MBC setting
    • Seoul, Korea, Republic of
      Pfizer Local Country Office
    Jun 28, 2022

    Metastatic Breast Cancer Trial in China, Korea, Republic of, Taiwan (sacituzumab govitecan (IMMU-132), Eribulin Mesylate

    Recruiting
    • Metastatic Breast Cancer
    • sacituzumab govitecan (IMMU-132)
    • +4 more
    • Beijing, China
    • +43 more
    Apr 19, 2022

    Metastatic Breast Cancer Trial in Seoul (Pembrolizumab)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Seoul, Korea, Republic of
      Yonsei Cancer Center at Yonsei University Health System
    Mar 14, 2022

    Metastatic Breast Cancer Trial in Seoul (Durvalumab with Tremelimumab)

    Completed
    • Metastatic Breast Cancer
    • Durvalumab with Tremelimumab
    • Seoul, Korea, Republic of
      Yonsei Cancer Center, Severance Hospital, Yonsei University Heal
    Dec 30, 2021

    Locally Advanced or, Metastatic Breast Cancer Trial in Korea, Republic of (Fulvestrant)

    Completed
    • Locally Advanced or
    • Metastatic Breast Cancer
    • Cheongju-si, Korea, Republic of
    • +8 more
    Sep 3, 2021

    Metastatic Breast Cancer Trial in Worldwide (PF-05280014, Paclitaxel, Herceptin®)

    Completed
    • Metastatic Breast Cancer
    • PF-05280014
    • +2 more
    • Plainville, Connecticut
    • +187 more
    Jun 7, 2021

    Locally Recurrent Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (NKTR-102, Treatment of Physician's Choice (TPC))

    Completed
    • Locally Recurrent Breast Cancer
    • Metastatic Breast Cancer
    • NKTR-102
    • Treatment of Physician's Choice (TPC)
    • Flagstaff, Arizona
    • +152 more
    May 6, 2021

    HER2-positive Breast Cancer, Metastatic Breast Cancer Trial in Seoul (Trastuzumab biosimilars(Herzuma), Gedatolisib)

    Unknown status
    • HER2-positive Breast Cancer
    • Metastatic Breast Cancer
    • Trastuzumab biosimilars(Herzuma), Gedatolisib
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Feb 16, 2021

    Metastatic Breast Cancer Trial in Worldwide (Atezolizumab, Trastuzumab emtansine, Placebo)

    Completed
    • Metastatic Breast Cancer
    • Orange, California
    • +67 more
    Jan 28, 2021

    Metastatic Breast Cancer, Locally Recurrent Breast Cancer Trial in Worldwide (Eribulin, Balixafortide)

    Unknown status
    • Metastatic Breast Cancer
    • Locally Recurrent Breast Cancer
    • Fresno, California
    • +87 more
    Nov 26, 2020

    Metastatic Breast Cancer Trial in Worldwide (OPT-822/OPT-821(30 µg/100 µg), Phosphate Buffer Saline (PBS), Cyclophosphamide)

    Completed
    • Metastatic Breast Cancer
    • OPT-822/OPT-821(30 μg/100 μg)
    • +2 more
    • Birmingham, Alabama
    • +42 more
    Sep 14, 2020

    Metastatic Breast Cancer Trial in Seoul (Everolimus(afinitor), Letrozole, Leuprolide(Lorelin Depot))

    Completed
    • Metastatic Breast Cancer
    • Seoul, Korea, Republic of
      Asan Medical Center
    Jul 29, 2020

    Metastatic Breast Cancer Trial in Seoul (Paclitaxel, Eribulin, Gemcitabine)

    Completed
    • Metastatic Breast Cancer
    • Seoul, Korea, Republic of
    • +1 more
    Jul 12, 2020

    Metastatic Breast Cancer Trial in Seoul (Poziotinib)

    Completed
    • Metastatic Breast Cancer
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jul 1, 2020

    Metastatic Breast Cancer Trial in Worldwide (Paclitaxel, AZD5363, Placebo)

    Unknown status
    • Metastatic Breast Cancer
    • Nantes, France
    • +45 more
    Feb 24, 2020

    Metastatic Breast Cancer Trial in Seoul (Genomic analysis)

    Recruiting
    • Metastatic Breast Cancer
    • Genomic analysis
    • Seoul, Korea, Republic of
      Samsung Medical Center, Sungkyunkwan University School of Medici
    Feb 5, 2020